Ruchi Kadam

A novel synergistic phycobiliprotein combination against HIV-1 shows potent antiviral activity

Human immunodeficiency virus type 1 (HIV-1) remains a major global public health challenge due to lifelong persistence, latency, and the emergence of drug resistance. Natural bioactive compounds are increasingly being explored as alternative or adjunct antiviral strategies. In th...